Novartis AG (NVS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 197.97B |
| Enterprise value | 210.47B |
| Trailing P/E | 24.85 |
| Forward P/E | 13.62 |
| PEG ratio (5-yr expected) | 1.66 |
| Price/sales (ttm) | 3.74 |
| Price/book (mrq) | 5.17 |
| Enterprise value/revenue | 3.88 |
| Enterprise value/EBITDA | 10.86 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.49 |
| 52-week change 3 | 5.48% |
| S&P500 52-week change 3 | 16.55% |
| 52-week high 3 | 105.61 |
| 52-week low 3 | 79.98 |
| 50-day moving average 3 | 96.16 |
| 200-day moving average 3 | 97.44 |
Share statistics
| Avg vol (3-month) 3 | 1.56M |
| Avg vol (10-day) 3 | 1.6M |
| Shares outstanding 5 | 2.06B |
| Implied shares outstanding 6 | 2.06B |
| Float 8 | 1.96B |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 7.32% |
| Shares short (14 Nov 2023) 4 | 3.65M |
| Short ratio (14 Nov 2023) 4 | 2.36 |
| Short % of float (14 Nov 2023) 4 | N/A |
| Short % of shares outstanding (14 Nov 2023) 4 | 0.19% |
| Shares short (prior month 12 Oct 2023) 4 | 3.22M |
Dividends & splits
| Forward annual dividend rate 4 | 3.5 |
| Forward annual dividend yield 4 | 3.65% |
| Trailing annual dividend rate 3 | 3.46 |
| Trailing annual dividend yield 3 | 3.61% |
| 5-year average dividend yield 4 | 3.56 |
| Payout ratio 4 | 90.64% |
| Dividend date 3 | 19 Mar 2023 |
| Ex-dividend date 4 | 08 Mar 2023 |
| Last split factor 2 | 1116:1000 |
| Last split date 3 | 08 Apr 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | 14.45% |
| Operating margin (ttm) | 28.53% |
Management effectiveness
| Return on assets (ttm) | 8.75% |
| Return on equity (ttm) | 16.45% |
Income statement
| Revenue (ttm) | 54.22B |
| Revenue per share (ttm) | 25.84 |
| Quarterly revenue growth (yoy) | 12.10% |
| Gross profit (ttm) | 36.74B |
| EBITDA | 21.59B |
| Net income avi to common (ttm) | 8.15B |
| Diluted EPS (ttm) | 3.86 |
| Quarterly earnings growth (yoy) | 12.00% |
Balance sheet
| Total cash (mrq) | 12.82B |
| Total cash per share (mrq) | 6.24 |
| Total debt (mrq) | 25.19B |
| Total debt/equity (mrq) | 65.86% |
| Current ratio (mrq) | 0.94 |
| Book value per share (mrq) | 18.57 |
Cash flow statement
| Operating cash flow (ttm) | 15.37B |
| Levered free cash flow (ttm) | 22.39B |
© 2023 Yahoo. All rights reserved.